| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.27 | 5e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |